Lv6
2217 积分 2025-03-14 加入
Phase 1/2 Study of Liposomal Irinotecan Plus S-1 for Metastatic Pancreatic Cancer Refractory to Gemcitabine-based Treatment
3天前
已完结
Evolution of ramucirumab in the treatment of cancer – A review of literature
6天前
已完结
Phase II Study of Capecitabine and Oxaliplatin for Advanced Adenocarcinoma of the Small Bowel and Ampulla of Vater
9天前
已完结
Outcomes of RALOX-HAIC-based Combination Therapy for Unresectable Hepatocellular Carcinoma with Radiomics-Powered Prediction
1个月前
已完结
Spatial immune scoring system predicts hepatocellular carcinoma recurrence
1个月前
已完结
Second-line treatment options for hepatocellular carcinoma: current state and challenges for the future
1个月前
已完结
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression
1个月前
已完结
Final overall survival analysis and exploratory biomarker study from JUPITER-06: a randomized phase 3 trial of toripalimab plus chemotherapy in advanced esophageal squamous cell carcinoma
1个月前
已完结
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype
1个月前
已完结
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial – Pembrolizumab Low Dose in Addition to NACT in TNBC]
1个月前
已完结
胰升糖素样肽-1(GLP-1)受体激动剂在多囊卵巢综合征中的临床应用专家共识
1个月前
已采纳
多功能协同凝胶聚合物电解质的构建及其宽温域锂金属电池性能
1个月前
已采纳
Evodiamine prevents dextran sulfate sodium-induced murine experimental colitis via the regulation of NF-κB and NLRP3 inflammasome
1个月前
已采纳
Naringin enhances reverse cholesterol transport in high fat/low streptozocin induced diabetic rats
1个月前
已采纳
Antigen-adjuvant effects of icariin in enhancing tumor-specific immunity in mastocytoma-bearing DBA/2J mice
1个月前
已采纳
Cardioprotective and anti-inflammatory effects of G-protein coupled receptor 30 (GPR30) on postmenopausal type 2 diabetic rats
1个月前
已采纳
短切碳纤维混凝土的基本力学性能与分析
1个月前
已采纳
难治性癫痫手术预后因素分析
1个月前
已采纳
皖公网安备34019202002308
